Q&A

3-year interval between Pap smears adequate for women with prior negative results

Author and Disclosure Information

  • BACKGROUND: The United States Preventive Services Task Force recommends that sexually active women receive Pap smears at least every 3 years. The American Cancer Society also recommends screening every 3 years for women aged >30 years with 3 prior normal Pap smear results.
  • POPULATION STUDIED: The authors analyzed data from the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which has offered cervical cancer screening to low-income, uninsured women throughout the United States since 1991. Women in this program are disproportionately of lower socioeconomic status and at higher risk for cervical neoplasia.
  • STUDY DESIGN AND VALIDITY: The researchers analyzed the NBCCEDP data to determine the prevalence of biopsy-proven cervical neoplasia in women with 1–3 recent negative Pap smears. They used a Markov model of cervical dysplasia progression to predict the risk of invasive cancer in the next 3 years, assuming yearly follow-up screening or screening 3 years after the last normal result. The definition of prior recent, negative Pap smears included those performed within 3 years of each other and reported as normal or indicating presence of infection or reactive changes.
  • OUTCOMES MEASURED: Measured outcomes were the excess risk of invasive cervical cancer associated with extended screening interval and the number of Pap smears and colposcopies required to prevent 1 case of cancer with more frequent screening.
  • RESULTS: Among women with 3 prior negative Pap smears, the estimated excess risk of cervical cancer associated with screening once at 3 years instead of yearly was 5 per 100,000 for women <30 years of age, 3 per 100,000 for women age 30 to 44, 1 per 100,000 for women 45 to 59, and 0 for women 60 to 64 years of age. Prevention of 1 case of cervical cancer through screening annually rather than once at 3 years would require an additional 42,621 Pap smears and 2364 colposcopies for women aged <30 years; 69,665 Pap smears and 3861 colposcopies for women aged 30 to 44; and 209,324 Pap smears with 11,502 colposcopies for women aged 45 to 59.


 

PRACTICE RECOMMENDATIONS

This study predicts that among women aged 30 to 64 years with 3 recent, negative Papanicolaou (Pap) smears, extending the interval for cervical cancer screening from 1 to 3 years would lead to an excess risk of cervical cancer of 3 in 100,000.

For women aged 30 to 44 years, preventing 1 case of cervical cancer through yearly Pap smears would require an additional 69,665 Pap smears and 3861 colposcopies (compared with screening 3 years after the last negative Pap smear). Clinicians should feel comfortable extending the interval for Pap smears from 1 to 3 years in women with prior normal results and a high likelihood of follow-up.

Recommended Reading

Should we screen for ovarian cancer?
MDedge Family Medicine
Water versus gel lubricant for cervical cytology specimens
MDedge Family Medicine
Metoclopramide reduces nausea from emergency contraception
MDedge Family Medicine
Clindamycin for vaginosis reduces prematurity and late miscarriage
MDedge Family Medicine
Zonisamide effective for weight loss in women
MDedge Family Medicine
Continuous use of oral contraceptives reduces bleeding
MDedge Family Medicine
Estrogen plus progestin may increase incidence of dementia
MDedge Family Medicine
Which cytology results predict cervical intraepithelial neoplasia?
MDedge Family Medicine
Routine induction reduces cesarean rate
MDedge Family Medicine
Aspirin prevents preeclampsia and complications
MDedge Family Medicine